Prostate hypertrophy, medically known as benign prostatic hyperplasia, is mainly characterized by frequent urination, urgency and urinary incontinence. At present, the clinical treatment mainly includes observation and waiting, behavior and diet adjustment, drug treatment, surgical treatment and so on. Details are as follows:

1. Observation and waiting, behavior and diet adjustment. Mainly suitable for patients with mild symptoms such as frequent urination and urgency, mainly to let patients know more about their disease state and quit smoking and drinking through physical exercise. Reasonable drinking water and avoiding excessive drinking water are expected to improve patients' symptoms.

2. medication. When patients have moderate or severe symptoms that affect their quality of life, they can be treated with drugs. At present, the commonly used drugs are: ① α receptor blockers, which can relax bladder smooth muscle and relieve symptoms such as obstruction, frequent urination and urgency. Commonly used drugs are tamsulosin, phenoxybenzamine and doxazosin. ② 5α reductase inhibitor can inhibit the production of dihydrotestosterone in vivo, reduce the volume of prostate, and then control the symptoms of benign prostatic hyperplasia. Commonly used drugs include finasteride and dutasteride. ③ M receptor antagonist can block the excitatory effect of M receptor, relieve the detrusor function of bladder, and relieve symptoms such as frequent micturition, urgency and nocturia. Commonly used drugs include tolterodine and oxybutine.